Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
79,794,643
-
Total 13F shares
-
6,602,351
-
Share change
-
+923,413
-
Total reported value
-
$27,731,268
-
Put/Call ratio
-
18%
-
Price per share
-
$4.20
-
Number of holders
-
57
-
Value change
-
+$3,273,477
-
Number of buys
-
31
-
Number of sells
-
20
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q1 2018
As of 31 Mar 2018,
Niagen Bioscience, Inc. - Common Stock (NAGE) was held by
57 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,602,351 shares.
The largest 10 holders included
ICONIQ Capital, LLC, VANGUARD GROUP INC, Tieton Capital Management, LLC, MILLENNIUM MANAGEMENT LLC, GOLDMAN SACHS GROUP INC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GEODE CAPITAL MANAGEMENT, LLC, Invesco Ltd., BlueCrest Capital Management Ltd, and UBS Group AG.
This page lists
57
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.